🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rapidly evolving virtual reality (VR) and augmented reality (AR) technologi...
Status
Unknown
Location
Naval Health Research Center
Start Date
2023-10-01
Trial ID
NCT05326100
Treatments Being Tested
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
The primary goal of the study is to evaluate the safety of the EndoLift Liv...
Status
Withdrawn
Location
Duke Regional Hospital
Start Date
2011-11
Trial ID
NCT02008409
Treatments Being Tested
The goal of this clinical trial is to determine the safety, efficacy, and c...
Status
Completed
Location
Vance Thompson Vision
Start Date
2023-06-26
Trial ID
NCT06085352
Treatments Being Tested
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Post-authorisation observational study to assess the evolution in normal cl...
Status
Completed
Location
Hospital Universitario Txagorritxu
Start Date
2012-12-17
Trial ID
NCT02085798
Treatments Being Tested
The study will evaluate the use of near infrared spectrometry (NIRS)in dete...
Status
Terminated
Location
University hospital Antwerp
Start Date
2018-09-28
Trial ID
NCT03757793
Treatments Being Tested
The purpose of this study is to evaluate the repeatability and reproducibil...
Status
Suspended
Location
London Vision Clinic
Start Date
2022-09-01
Trial ID
NCT03473847
To test the ability of GSK256073 to block niacin-induced flushing when GSK2...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12
Trial ID
NCT00608699
Treatments Being Tested
This is a controlled, randomized, subject-masked, 3x3 crossover, non-dispen...
Status
Completed
Location
The University of Manchester
Start Date
2018-11-07
Trial ID
NCT03733899
Treatments Being Tested